Cardiac MRI Contrast Agents Carry Low Risk of Adverse Events
By A Mystery Man Writer
Description
Researchers analyzed data from 154,779 patients who underwent cardiac MRI, 95% of whom received a gadolinium-based contrast agent
Diagnostic and Interventional Cardiology
MRI Contrast Safety: Possible Gadolinium Side Effects
Cardiac MRI Contrast Agents Carry Low Risk of Adverse Events
Patient Safety - Page 4 of 20 - Express Healthcare
JCDD, Free Full-Text
MRI contrast agent safety Radiology Reference Article
Mid-wall striae fibrosis predicts heart failure admission
Contrast Media
Gadolinium-based contrast agents are safe, even at higher doses
Intravenous Imaging Contrast Media Complications: The Basics That
Development and Use of Elucirem™ (gadopiclenol) Injection, a
CT Scan with IV Contrast Patient Fact Sheet
Diagnostic and Interventional Cardiology
Diagnostic and Interventional Cardiology
New contrast agent earns positive safety classification from ACR
from
per adult (price varies by group size)